Back to Bank of New York Mellon Corp Bank of New York Mellon Corp

MIRMMIRM
Showing 8 of 23 quarters

Position history for Bank of New York Mellon CorpBank of New York Mellon Corp's holdings in MIRUM PHARMACEUTICALS INC

Bank of New York Mellon Corp holds 669,974 shares of MIRM (MIRUM PHARMACEUTICALS INC), worth $78.4M as of 2026-Q2. The position was increased (+14.6% shares). MIRM represents 0.0% of Bank of New York Mellon Corp's portfolio.

Current Value

$78.4M

Current Shares

669,974

Total Value Change

+$74M

Total Shares Change

+555,275

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
669,974
+14.6%
$78.4M0.0%$117.07
34
2026-Q1
Increased
584,523
+3.4%
$54M0.0%$87.80
30
2025-Q4
Increased
565,579
+26.9%
$44.7M0.0%$78.85
36
2025-Q3
Decreased
445,527
-10.2%
$32.7M0.0%$72.85
0
2025-Q2
Increased
496,061
+101.0%
$25.2M0.0%$51.09
46
2025-Q1
Increased
246,730
+98.5%
$11.1M0.0%$45.99
45
2024-Q4
Increased
124,328
+8.4%
$5.1M0.0%$41.18
29
2024-Q3
Decreased
114,699
-19.8%
$4.5M0.0%$38.85
0

Other major holders of MIRM: Janus Henderson Group Ltd., BlackRock, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used